Soluble ST2 proteins in male cachectic patients with chronic heart failure

Until now, there are lack of established clinical factors allowing management of chronic heart failure (CHF) patients being at risk of cardiac cachexia (CC). The changes in soluble protein ST2 (sST2) concentrations suggest a valuable and prognostic usefulness of this biomarker in monitoring patients...

Full description

Saved in:
Bibliographic Details
Published in:Nutrition, metabolism, and cardiovascular diseases metabolism, and cardiovascular diseases, 2021-03, Vol.31 (3), p.886-893
Main Authors: Sobieszek, Grzegorz, Powrózek, Tomasz, Jaroszyński, Andrzej, Skwarek-Dziekanowska, Aneta, Rahnama-Hezavah, Mansur, Małecka-Massalska, Teresa
Format: Article
Language:English
Subjects:
Aged
Aged, 80 and over
Bioelectrical impedance analysis
biomarkers
Biomarkers - blood
Body Composition
Cachexia
Cachexia - blood
Cachexia - diagnosis
Cachexia - mortality
Cachexia - physiopathology
Chronic Disease
Chronic heart failure
correlation
death
detection
guidelines
heart failure
Heart Failure - blood
Heart Failure - diagnosis
Heart Failure - mortality
Heart Failure - physiopathology
Humans
Interleukin-1 Receptor-Like 1 Protein - blood
Male
males
metabolism
Middle Aged
monitoring
mortality
nutrition
patients
prediction
Prognosis
proteins
risk
Risk Assessment
Risk Factors
screening
sST2
testing
Time Factors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!